Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma

NCT00042913 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: epratuzumab

Sponsor

Jonsson Comprehensive Cancer Center

Collaborators

[object Object]